| Hangzhou Viwa Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.viwachina.com | |||
![]() | +86 (571) 5683-6886 5683-2058 5683-6878 | |||
![]() | +86 (571) 8717-5163 / 8785-8383 | |||
![]() | sales@viwachina.com | |||
| Chemical manufacturer since 2004 | ||||
| chemBlink Standard supplier since 2007 | ||||
| Hefei TNJ Chemical Industry Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.tnjchem.com | |||
![]() | +86 (551) 6541-8684 | |||
![]() | +86 (551) 6541-8697 | |||
![]() | sales@tnjchem.com | |||
| Chemical manufacturer since 2001 | ||||
| chemBlink Standard supplier since 2010 | ||||
| Amadis Chemical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.amadischem.com | |||
![]() | +86 (571) 8992-5085 | |||
![]() | +86 (571) 8992-5065 | |||
![]() | sales@amadischem.com | |||
| Chemical manufacturer since 2010 | ||||
| chemBlink Standard supplier since 2015 | ||||
| Cambrex Corporation | USA | Inquire | ||
|---|---|---|---|---|
![]() | www.cambrex.com | |||
![]() | +1 (201) 804-3000 | |||
![]() | +1 (201) 804-9852 | |||
![]() | info@cambrex.com | |||
| Chemical manufacturer | ||||
| Hunan Dongting Pharmaceutical Co., Ltd. | China | Inquire | ||
|---|---|---|---|---|
![]() | www.dtpharm.com | |||
![]() | +86 (736) 731-2155 | |||
![]() | +86 (736) 731-3818 | |||
![]() | impexp@dtpharm.com | |||
| Chemical manufacturer | ||||
| Classification | API >> Nervous system medication >> Other nervous system medication |
|---|---|
| Name | Lorazepam |
| Synonyms | 7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one |
| Molecular Structure | ![]() |
| Molecular Formula | C15H10Cl2N2O2 |
| Molecular Weight | 321.16 |
| CAS Registry Number | 846-49-1 |
| EC Number | 212-687-6 |
| Hazard Symbols | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Risk Statements | R63 Details | ||||||||||||||||||||||||||||||||||||
| Safety Statements | S36/37 Details | ||||||||||||||||||||||||||||||||||||
| Hazard Classification | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Controlled Substance | DEA Drug Code Number: 2885 Details | ||||||||||||||||||||||||||||||||||||
| CSA Schedule: IV | |||||||||||||||||||||||||||||||||||||
| Narcotics? No | |||||||||||||||||||||||||||||||||||||
| SDS | Available | ||||||||||||||||||||||||||||||||||||
| Market Analysis Reports |
| List of Reports Available for Lorazepam |